We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

16 hedge funds and large institutions have $6.28M invested in Tenax Therapeutics in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

7% more funds holding

Funds holding: 15 → 16 (+1)

1% more capital invested

Capital invested by funds: $6.24M → $6.28M (+$44K)

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$31.3K
2
TRCT
Tower Research Capital (TRC)
New York
+$14.7K
3
TSS
Two Sigma Securities
New York
+$14.7K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7K
5
UBS Group
UBS Group
Switzerland
+$11K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$708K
2
Renaissance Technologies
Renaissance Technologies
New York
-$116K
3
Two Sigma Investments
Two Sigma Investments
New York
-$101K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$92K
5
VF
Virtu Financial
New York
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$3.76M – – –
BlackRock
2
BlackRock
New York
$1.11M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$794K -$116K -63 -19%
FWP
4
FAS Wealth Partners
Kansas
$108K -$1.84K -1 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$99K +$14.7K +8 +32%
Two Sigma Investments
6
Two Sigma Investments
New York
$73K -$101K -55 -69%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$61K – – –
Ameriprise
8
Ameriprise
Minnesota
$56K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$51K +$31.3K +17 New
Two Sigma Advisers
10
Two Sigma Advisers
New York
$41K -$92K -50 -78%
TRCT
11
Tower Research Capital (TRC)
New York
$33K +$14.7K +8 +267%
Northern Trust
12
Northern Trust
Illinois
$32K – – –
TSS
13
Two Sigma Securities
New York
$24K +$14.7K +8 New
William Blair & Company
14
William Blair & Company
Illinois
$19K – – –
UBS Group
15
UBS Group
Switzerland
$17K +$11K +6 New
BCV
16
Banque Cantonale Vaudoise
Switzerland
$2K – – –
TCM
17
Tang Capital Management
California
– -$708K -288 Closed
VF
18
Virtu Financial
New York
– -$33K -13 Closed

TENX Hedge Fund Activity: Q4 2020 in Review

16 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2020, worth a combined $6.28M — up 0.71% from $6.24M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TENX positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $31.3K. The largest seller was Tang Capital Management, exiting entirely with an estimated $708K sold.

  • 16 institutional investors held Tenax Therapeutics (TENX) as of Q4 2020, up from 15 in Q3 2020.
  • Funds reported $6.28M of Tenax Therapeutics stock for Q4 2020, up 0.71% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q4 2020 and 2 closed out, a net change of +1 holder.
  • The largest Tenax Therapeutics buyer in Q4 2020 was Citadel Advisors, an estimated $31.3K added.
  • The largest Tenax Therapeutics seller in Q4 2020 was Tang Capital Management, an estimated $708K sold.

Based on aggregated 13F filings for Q4 2020.